NLRP3 and Sepsis: The mtDNA serves as a viable plasma biomarker for critically ill patients (Nakahira et al., 2013; Johansson et al., 2018), and activates NLRP3 to trigger cytokine release and exacerbate the inflammatory response of sepsis.